Search Results
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Johan Svensson in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Åsa Tivesten in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Klara Sjögren in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Olle Isaksson in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Göran Bergström in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Subburaman Mohan in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Johan Mölne in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Jörgen Isgaard in
Google Scholar
PubMed
Department of Clinical Physiology, Göteborg University, Göteborg, Sweden
Musculoskeletal Disease Center, Jerry L Pettis Memorial VA Medical Center, Loma Linda, California, USA
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
). In diabetic as well as non diabetic end-stage renal failure, there are marked abnormalities in the GH/IGF-I system ( Jain et al. 1998 , Rabkin & Schaefer 2004 ). In humans with diabetes mellitus (DM) type I, circulating IGF-I is low and
Search for other papers by Alaa E S Abdel-Razik in
Google Scholar
PubMed
Search for other papers by Ellen J Forty in
Google Scholar
PubMed
Search for other papers by Richard J Balment in
Google Scholar
PubMed
Search for other papers by Nick Ashton in
Google Scholar
PubMed
. 2002 ). Furthermore, recent evidence now suggests that UTS may play a role in regulating renal function in mammals. The kidney is a major source of UTS in humans ( Nothacker et al . 1999 ), primates, mice ( Elshourbagy et al . 2002 ) and rats ( Song
Search for other papers by Kayte A Jenkin in
Google Scholar
PubMed
Search for other papers by Lannie O'Keefe in
Google Scholar
PubMed
Search for other papers by Anna C Simcocks in
Google Scholar
PubMed
Search for other papers by Esther Grinfeld in
Google Scholar
PubMed
College of Health and Biomedicine, The Florey Institute of Neuroscience and Mental Health, Department of Physiology, Centre for Chronic Disease Prevention and Management, Victoria University, St Albans Campus, PO Box 14428, Melbourne, Victoria 8001, Australia
Search for other papers by Michael L Mathai in
Google Scholar
PubMed
Search for other papers by Andrew J McAinch in
Google Scholar
PubMed
Search for other papers by Deanne H Hryciw in
Google Scholar
PubMed
, it is important to identify physiological targets, which may ameliorate the progression of obesity and the subsequent decline in renal function. The endocannabinoid system has been characterised as an important endogenous lipid signalling system
Search for other papers by Emily G Farrow in
Google Scholar
PubMed
Search for other papers by Lelia J Summers in
Google Scholar
PubMed
Search for other papers by Susan C Schiavi in
Google Scholar
PubMed
Search for other papers by James A McCormick in
Google Scholar
PubMed
Search for other papers by David H Ellison in
Google Scholar
PubMed
Search for other papers by Kenneth E White in
Google Scholar
PubMed
hyperphosphatemic tumoral calcinosis (TC). In situations of elevated FGF23, renal phosphate wasting occurs through down-regulation of the proximal tubule (PT) membrane type-IIa (Npt2a) and type-IIc (Npt2c) sodium phosphate co-transporters ( Larsson et al . 2004
Search for other papers by Georgios A Christou in
Google Scholar
PubMed
Search for other papers by Dimitrios N Kiortsis in
Google Scholar
PubMed
cardiovascular disease (CVD) in obese or overweight patients ( Hotta et al . 2000 ). Adiponectin is currently considered to be eliminated through renal biodegradation/excretion, but this mechanism has been proposed mostly on the basis of indirect data ( von
Search for other papers by Li Juan He in
Google Scholar
PubMed
Search for other papers by Min Liang in
Google Scholar
PubMed
Search for other papers by Fan Fan Hou in
Google Scholar
PubMed
Search for other papers by Zhi Jian Guo in
Google Scholar
PubMed
Search for other papers by Di Xie in
Google Scholar
PubMed
Search for other papers by Xun Zhang in
Google Scholar
PubMed
Introduction Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal failure in many countries. Although hyperglycemia is the underlying metabolic abnormality, many other mechanisms have also been proposed for
Search for other papers by Claire E Hills in
Google Scholar
PubMed
Search for other papers by Paul E Squires in
Google Scholar
PubMed
Search for other papers by Rosemary Bland in
Google Scholar
PubMed
Introduction Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal disease in the US and Europe (reviewed in Ritz 1999 ). This condition includes both structural and functional alterations in the kidney of the
Search for other papers by Youichi Sato in
Google Scholar
PubMed
Search for other papers by Takanobu Kamada in
Google Scholar
PubMed
Search for other papers by Aiko Yamauchi in
Google Scholar
PubMed
inhibitors and the role of DPP4 in various tissues are not fully understood. We previously showed that DPP4-deficient rats developed renal dysfunction when compared with WT rats following streptozotocin (STZ) treatment to induce diabetes. Creatinine clearance
Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Search for other papers by Shun-Neng Hsu in
Google Scholar
PubMed
Search for other papers by Louise A Stephen in
Google Scholar
PubMed
Search for other papers by Scott Dillon in
Google Scholar
PubMed
Search for other papers by Elspeth Milne in
Google Scholar
PubMed
Search for other papers by Behzad Javaheri in
Google Scholar
PubMed
Search for other papers by Andrew A Pitsillides in
Google Scholar
PubMed
Search for other papers by Amanda Novak in
Google Scholar
PubMed
Search for other papers by Jose Luis Millán in
Google Scholar
PubMed
Search for other papers by Vicky E MacRae in
Google Scholar
PubMed
Search for other papers by Katherine A Staines in
Google Scholar
PubMed
Search for other papers by Colin Farquharson in
Google Scholar
PubMed
of CKD–mineral bone disorder (CKD–MBD) which develops in the early stages of CKD and disease progression can result in cardiovascular disease and renal osteodystrophy (ROD) – the skeletal pathology component of the CKD-MBD syndrome ( Fang et al
Division of Clinical Epigenetics, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan
Search for other papers by Shigeru Shibata in
Google Scholar
PubMed
body mainly by acting on the distal part of the renal nephron (which normally includes distal convoluted tubules (DCTs), connecting tubules and collecting duct). Although NaCl reabsorbed in the distal segment represents only a fraction of that handled